fda semaglutide shortage resolved february 21 2025 Wegovy, Ozempic declared over, hitting copycats like Hims & Hers Novo Nordisk's semaglutide shortage officially

During the item generation and discussion and clarification phases, the experts identified 14 distinct challenges: costs, supply challenges, lack of evidence, polypharmacy, barriers to prescription, lack of knowledge, adherence concerns, aversion to injection therapy, clinical inertia, titration needs, perceived health state, fear of adverse effects, lack of clinical guideline recommendations, and lack of measurable outcomes to guide therapy

Many products combine ingredients like copper peptides, Matrixyl, and Argireline into one formula, making it easier to support collagen, firmness, and the appearance of expression lines

In comparison, a randomised controlled trial in 1,961 people showed that 69% of participants on Wegovy achieved more than 10% weight loss, with 50% achieving more than 15%

The Lean Mass Question The more pressing clinical concern is whats happening to body composition

If theres any silver lining in this cancer journey, its the fact that we caught it early

International Journal of Sport Nutrition and Exercise Metabolism